Allied Market Research published a report, titled, “Organ-on-Chip Market by Type (Heart on chip, Human on chip, Intestine on chip, Kidney on chip, Liver on chip, Lung on chip): Global Opportunity Analysis and Industry Forecast, 2020-2030.” According to the report, the global organ-on-chip industry was estimated at $103.44 million in 2020, and is anticipated to hit $1.6 billion by 2030, registering a CAGR of 31.1% from 2021 to 2030.
What is the estimated industry size of Organ-on-Chip?
The total market value of organ-on-chip market is $103.44 million in 2020.
What is the leading application of Organ-on-Chip Market?
Lung-on-chip segment dominated the market in 2020, and is expected to remain dominant during the forecast period, owing to lower lung transplantations, which has led to development of laboratory engineered chips to mimic their functions and for drug screening for respiratory disorders and is expected to drive the segment.
♦ Download Free Sample PDF Now (Including Full TOC, Table & Figures):
Value Propositions Related to The Report:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
Covid-19 Situation –
- Organ-on-Chip emerged as a favorable technology for the development of vaccines & drugs, which were under clinical trials. This, in turn, impacted the global organ-on-chip market positively.
- This trend is most likely to persist till the pandemic is completely over.
♦ Simply Speak to Expert for More Clarification of [COVID-19 on Your Business}:
The lung on chip segment to maintain the dominant share –
Based on product, the lung segment holds more than one-fifth of the revenue in the global device-on-a-chip market in 2020 and is expected to lead way in the year 2030. Reduced lung turnover has led to the development. of on-a-chips designed in the laboratory to mimic their function. This makes the growth of the organ appear. The heart attack segment, on the other hand, will show the fastest CAGR of 32.8% from 2021 to 2030, due to the increase in heart problems among people across the world.
North America garnered the major share in 2020 –
Based on region, North America has the largest share in 2020, accounting for more than two-fifths of the global parts-on-chip market. This is due to the rapid adoption of advanced technology and the presence of major players across North America. The Asia-Pacific region, meanwhile, will see the fastest growth at a CAGR of 33.1% by 2030, due to increased R&D for the development of component-on-chip models.
Major Key Market Players in the Industry –
- BICO Group AB(Visikol)
- CN Bio Innovations Limited
- Emulate, Inc.
- AxoSim Technologies LLC
- Nortis Inc.
- Tara Biosystems
- Organovo Holdings, Inc.
- Insphero AG
- Mimetas B.V.
♦ Inquire More About the Top Key Market Players Here:
Market: By Region Outlook
- North America (U.S., Canada, Mexico)
- Europe (UK, Germany, France, Spain, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
- LAMEA (Brazil, South Africa, Turkey, Saudi Arabia, Rest of LAMEA)
Important Questions Being Answered by This Market Report Are –
Q1. What are the upcoming trends of Organ-on-Chip Market in the world?
Q2. Which are the top companies to hold the market share in Organ-on-Chip?
Q3. Which is the largest regional market for Organ-on-Chip?
♦ Request for Customization:
Depending on type, the organ-on-chip market analysis lung-on-chip segment generated maximum revenue in 2020, accounting for $21.37 million. The heart-on-chip segment is expected to witness highest CAGR of 32.8% during the forecast period.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060